Hsbc Holdings PLC Inovio Pharmaceuticals, Inc. Transaction History

Hsbc Holdings PLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	SELL	$1.44 - $3.98 $7,601 - $21,010	-5,279 Reduced 11.07%	42,393 $73,000
Q1 2022 May 16, 2022	BUY	$2.97 - $5.2 $19,230 - $33,670	6,475 Added 15.72%	47,672 $171,000
Q3 2021 Nov 12, 2021	SELL	$7.16 - $9.69 $87,616 - $118,576	-12,237 Reduced 22.9%	41,197 $295,000
Q2 2021 Aug 13, 2021	BUY	$6.23 - $10.03 $74,348 - $119,698	11,934 Added 28.76%	53,434 $495,000
Q1 2021 May 14, 2021	SELL	$8.81 - $16.96 $132,590 - $255,248	-15,050 Reduced 26.61%	41,500 $385,000
Q4 2020 Feb 12, 2021	BUY	$8.5 - $12.85 $360,561 - $545,084	42,419 Added 300.18%	56,550 $500,000
Q3 2020 Nov 12, 2020	SELL	$9.57 - $27.05 $10,421 - $29,457	-1,089 Reduced 7.16%	14,131 $164,000
Q2 2020 Aug 14, 2020	BUY	$7.14 - $31.69 $108,670 - $482,321	15,220 New	15,220 $410,000

281K

Ticker INO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 249,400,000
Market Cap $1.41B
Description
Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its DNA medicines platform uses precisely designed SynCon that identify and optimize the DNA se...

Get notified when there are updates to the investment portfolio of Hsbc Holdings PLC, based on Form 13F filings with the SEC.

Stay updated on Hsbc Holdings PLC with notifications on news.